847
Participants
Start Date
April 30, 2011
Primary Completion Date
January 31, 2012
Study Completion Date
January 31, 2012
NB-001
Topical, 5 times daily until investigator assessment of healing or a maximum of 4 days
Vehicle
Topical, 5 times daily until investigator assessment of healing or a maximum of 4 days
Axis Clinical Trials, New Hyde Park
Upstate Clinical Research Associates, Williamsville
Rochester Clinical Research, Inc., Rochester
Paramount Clinical Research, Bridgeville
IntegraTrials, LLC, Arlington
National Clinical Research, Richmond
Radiant Research, Inc., Anderson
Altus Research, Inc., Lake Worth
Tampa Bay Medical Research, Clearwater
Radiant Research, Inc, Pinellas Park
Suncoast Clinical Research, New Port Richey
Radiant Research, Inc., Birmingham
DermResearch, Louisville
Commonwealth Biomedical Research, Madisonville
Radiant Research, Inc., Akron
Radiant Research, Inc., Cincinnati
Radiant Research, Inc. Chicago, Chicago
Radiant Research, Inc., St Louis
The Center for Pharmaceutical Research, P.C., Kansas City
Meridian Clinical Research, Omaha
Research Across America, Dallas
Benchmark Research - San Angelo, San Angelo
Radiant Research, Inc., San Antonio
DermResearch, Inc., Austin
Front Range Clinical Research, Wheat Ridge
South Valley Dermatology, West Jordan
Utah Clinical Trials, LLC, Salt Lake City
Elite Clinical Studies, LLC, Phoenix
Radiant Research, Inc, Tucson
Axis Clinical Trials, Los Angeles
Axis Clinical Trials, Los Angeles
Staywell Research, Northridge
Providence Clinical Research, Burbank
Dermatology & Laser Center NW, Bellingham
Omega Medical Research, Warwick
Lead Sponsor
NanoBio Corporation
INDUSTRY